Filipino-founded firm developing test to detect ovarian cancer with a drop of blood

MANILA, Philippines – Filipino-founded biotech firm InterVenn Biosciences on Friday, July 22, launched its Philippine office. Though the company is headquartered in San Francisco, California, the team that developed and maintains the proprietary AI technology that speeds up certain research processes for the company is made up mostly of Filipinos residing in the Philippines, including one of its founders, AI and blockchain expert Aldo Carrascoso. The company has about 150 Filipinos working in the Philippines, majority of whom are software developers, and who make up half of the company. Through the help of the company's advanced AI platform, the company is able to help its global groups of researchers and scientists significantly reduce the time it takes for some processes such as analysis of samples from months to seconds. It's through this meaningful application of AI that the firm has been able to make strides in the field since its founding in 2017, as well as strides in funding.